Weight-loss drug to be sold over-the-counter
22 January 2009
Weight-loss drug orlistat is set to be available over-the-counter (OTC) later this year.
Photograph: Virgo HEALTH
GlaxoSmithKline (GSK) has received European approval for orlistat 60mg to be available as a pharmacy-only medicine. The drug will be available in the coming months, marketed as Alli.
It will be licensed for treatment of adults with a BMI over 28 who are on a reduced calorie, low-fat diet.
Pharmacy staff will be trained to provide appropriate advice to customers wanting to buy the product, GSK said.
tom.moberly@haymarket.com
Comment below and tell us what you think
Additional Information
Latest jobs Jobs web feed
- Salaried GP The Practice plc £75-85k FTE +NHS pension, Ely or Leicester
- Regional Clinical Leads The Practice plc Salary £95-105k FTE + NHS pension, Leicester or Sheffield
- Salaried/Lead GPs Malling Health Competitive, role dependant, NHS Pension and defence fees reimbursed, Nationwide
- Locums GP Wolverhampton Pegasus Medical £70 per hour, Wolverhampton and West Midlands long term
- Locum GP Leeds and Surrounding Area Pegasus Medical £70 - £75 per hour, Leeds and Yorkshire long term
- Locums GP Walsall Pegasus Medical £70 per hour, Walsall and West Midlands long term
Most read
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
